Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study

To evaluate the efficacy and safety of bevacizumab when added to first-line oxaliplatin-based chemotherapy (either capecitabine plus oxaliplatin [XELOX] or fluorouracil/folinic acid plus oxaliplatin [FOLFOX-4]) in patients with metastatic colorectal cancer (MCRC). Patients with MCRC were randomly as...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of clinical oncology 2023-07, Vol.41 (21), p.3663-3669
Hauptverfasser:	Saltz, Leonard B, Clarke, Stephen, Díaz-Rubio, Eduardo, Scheithauer, Werner, Figer, Arie, Wong, Ralph, Koski, Sheryl, Lichinitser, Mikhail, Yang, Tsai-Shen, Rivera, Fernando, Couture, Felix, Sirzén, Florin, Cassidy, Jim
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!